Standout Papers

Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial 2019 2026 2021 2023 360
  1. Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial (2019)
    Robert D. McBane, Waldemar E. Wysokiński et al. Journal of Thrombosis and Haemostasis

Immediate Impact

63 standout
Sub-graph 1 of 21

Citing Papers

Opportunities in the Postpartum Period to Reduce Cardiovascular Disease Risk After Adverse Pregnancy Outcomes: A Scientific Statement From the American Heart Association
2024 Standout
Glioblastoma and Other Primary Brain Malignancies in Adults
2023 Standout
5 intermediate papers

Works of Stanislav Henkin being referenced

Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial
2019 Standout
Impact of a History of Hypertension in Pregnancy on Later Diagnosis of Atrial Fibrillation
2018

Author Peers

Author Last Decade Papers Cites
Stanislav Henkin 668 366 202 567 63 1.1k
David Spirk 504 459 80 881 63 1.1k
Ruud Oudega 515 314 60 858 44 1.3k
Cynthia Wu 544 229 69 808 54 1.1k
Paul R. Daniels 639 410 96 613 43 1.1k
Gerald Chi 700 342 132 524 95 1.3k
Craig R. Narins 600 580 365 175 42 1.1k
Esteban Gándara 521 183 88 701 42 957
Michele G. Beckman 509 258 93 876 36 1.2k
Timothy K. Liem 307 735 570 265 77 1.3k
Nicola Mumoli 376 297 179 401 103 1.1k

All Works

Loading papers...

Rankless by CCL
2026